India’s Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand, ET HealthWorld
Bengaluru: Dr Lal PathLabs, India’s biggest diagnostics firm by revenue, posted a bigger profit for the fourth straight quarter on Thursday, led by the addition of more labs and increased demand for medical tests.
The company’s consolidated net profit jumped 49 per cent year-on-year to 845 million rupees ($10.1 million) in the fourth quarter.
Its shares climbed as much as 7.8 per cent after the results before trimming some gains to trade up about 6 per cent. Rival Metropolis Healthcare was up about 2 per cent and Thyrocare Technologies gained about 1 per cent.
Analysts expect Indian diagnostic firms to
